International Medical Journal (ISSN:13412051)

Aim and Scope

Aim-

International Medical Journal ISSN: (13412051) is an international open-access journal publishes twelve times each year. The "International Medical Journal" is a peer-reviewed, monthly, online international research journal, which publishes original articles, research articles, review articles with top-level work from all areas of Medical Science Research and their application including Aetiology, bioengineering, biomedicine, cardiology, chiropody, ENT etc. Researchers in all Medical Science and Pharmacy fields are encouraged to contribute articles based on recent research. Journal publishes research articles and reviews within the whole field of Medical Science and Pharmacy Research, and it will continue to provide information on the latest trends and developments in this ever-expanding subject. International Medical Journal journal covers almost all disciplines of Medical Science and Pharmacy. Researchers and students of M.B.B.S, M.D., D.T.C.D., GYNE., M.S., M.Pharma, And PhD are requested to send their original research articles to International Medical Journal.

Scope-

International Medical Journal ISSN: (13412051) is a peer-reviewed journal. The journal seeks to publish original research articles that are hypothetical and theoretical in its nature and that provide exploratory insights in the following fields but not limited to:

Anatomy Physiology Biochemistry Pharmacology
Pathology Forensic medicine Microbiology Community Medicine
Otorhinolaryngology Internal Medicine General Surgery Obstetrics and Gynecology
Radiology Pulmonary Medicine Dermatology and Venereal diseases Infectious Diseases
Anaesthesia Cancer research Neurosurgery Orthopedics

See More Scopes

Latest Journals
International Medical Journal
Journal ID : IMJ-08-09-2020-604
Total View : 347

Abstract : Chemotherapy-induced peripheral neuropathy (CIPN) is one of the side effects related to chemotherapy treatment. The incidence ranges between 30 and 70 %. The current study was conducted to identify the use and effectiveness of coping strategies and their association with QOL among patients with CIPN. A cross-sectional correlational design using a convenience sampling approach was used in the current study. A sample of 100 participants was used to produce the study’s surveys including demographical and clinical information, an Arabic version of the quality of life questionnaire - chemotherapy-induced peripheral neuropathy (QLQ-CIPN20) and Arabic version of Jalowiec Coping Scale (JCS). Findings showed that confrontive coping strategies were the most commonly used by the participants (Mean =24.45, SD = 2.10) and also the effective (Mean 24.62, SD = 1.69). Strong negative relationships were found between use of coping strategies and QLQ-CIPN20 (r = -0.76, p<0.001) and strong negative relationships were found between effectiveness of coping strategies and QLQ-CIPN20 (r = -0.73, p<0.001). Since there is no reliable treatment for CIPN, therapeutic interventions that reduce the impact of CIPN through increasing the use of coping strategies is highly recommended in the treatment plan.
Full article
International Medical Journal
Journal ID : IMJ-07-09-2020-601
Total View : 350

Abstract : Dyspepsia or functional dyspepsia (FD) is a term often used to describe the abdominal discomfort and commonly used by many clinicians to account the various symptoms frequently observed in majority of patient of gastrointestinal disorder. FD possesses the group of common symptoms which draw the difference other than peptic ulcer disease and may lead to development of metabolic diseases if not treated within a framework. This review article emphasized on the functional dyspepsia and potential features of unique formulation i.e Unienzyme with MPS in the management of unenviable sign and symptoms of functional dyspepsia or non-ulcer dyspepsia.
Full article
International Medical Journal
Journal ID : IMJ-03-09-2020-598
Total View : 0

Abstract : Bay or laurel is a natural plant and its leaves are one of the fundamental regularly used cooking spices. The dry bay leaves are used to treat numerous digestive issues with nonvascular and antibacterial marketers. As a result, this examine turned into aimed to assess biological hobby of Jordanian bay leaves for its microbiological hobby in-vitro by way of extraction crucial oils from sparkling and dry leaves. The dried bay leaves have been extracted via hydro- distillation the use of methanol by means of a soxhlet extractor. The extracts had been focused and evaluated for mic assessments against bacillus coagulant, lactobacillus, streptococcus and candida albicans. In addition, bay leaves extracts have been evaluated for antioxidant activity the usage of dpph assay. The minimum inhibitory awareness (mic) confirmed that methanolic- extract of bay leaves has giant effects against bacillus coagulant and lactobacillus, where detectable effects towards other tested microorganism. But, all of bay leaves extracts displayed no consequences on candida albicans, however the methanolic extract displayed the most prominent stage. The oils confirmed true antibacterial interest towards each gram negative and gramtremendous microorganism. The capacity antioxidant pastime of the bay leaves and methanolic extract of seed oil from l. Nobili’s were evaluated to 94. 65(μg/ml) of DPPH ic 50.
Full article
International Medical Journal
Journal ID : IMJ-31-08-2020-596
Total View : 0

Abstract : Depression is one of the most common medical illnesses worldwide. Medical students during their training will be subjected to many stressors both mental and emotional. The Objectives of this study is to assess the prevalence of depression among medical students. And to identify any association between depression and some socio-demographic factors. A descriptive cross-sectional study was conducted in Baghdad city; the study sample was medical students from all the six stages at Al-Kindy College of medicine. Out of a total of 800 students, only a convenient sample of 301 students were selected and they agreed to participate in the current study. Data were collected using a self-administered questionnaire form. Statistical analysis was done by using IBM/SPSS version 25(Statistical Package for social science) computer software. The overall prevalence of depression symptoms is 55.48% among students. The stage of the study, gender, and social relationship are significantly associated with depression symptoms, with no significant association between chronic disease and monthly family income. The higher percentage of depression was among the first, third and fourth years. the highest depression symptoms 73.1%, were among female students 59.9%. social students with (P value less than 0.05) High level of depressive symptoms among students in Al-Kindy College of medicine was reported with a female being more depressed than males, More than half of participants show these symptoms and most of those students are in the pre-clinical stage whereas the lowest level appears among sixth stage students.
Full article
International Medical Journal
Journal ID : IMJ-26-08-2020-591
Total View : 493

Abstract : During the search for treatments for COVID-19, clinical trials for testing hydroxychloroquine were interrupted by the WHO already on May 25, 2020 after publication of a paper in the magazine The Lancet [2] that stated that patients who had received hydroxychloroquine presented mortality rates of 35% due to severe cardiac arrhythmias. This paper was withdrawn thirteen days after its publication because it was questioned by 120 scientists of various nationalities [3], both as regards the data collected and as regards the method, and on June 2, 2020 also eighty Italian medical doctors sent a letter to The Lancet and to the WHO in which they criticized the scientific contents of the paper. [4] Then, on June 3, 2020, Dr. Tedros Adhanom Ghebreyesus, Director-General of the WHO, allowed restart of recruitment of patients in tests regarding hydroxychloroquine in the Solidarity trial. [5] The Recovery trial then became the principal study on which the WHO based its final decision to confirm for all drug agencies suspension of use of hydroxychloroquine for the treatment of COVID-19.
Full article

Our Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates